Fig. 3: EIF5A2 is highly expressed in NSCLC.
From: Eukaryotic initiation factor 5A2 mediates hypoxia-induced autophagy and cisplatin resistance
A Expression analysis based on the TCGA-LUAD cohort showing that eIF5A2 expression in NSCLC tissues was significantly higher than that in adjacent normal tissues. B–E Western blotting results validating the overexpression of eIF5A2 in both NSCLC cell lines (B, C) and tissues (D, E). F Survival curve indicating that patients with NSCLC with low eIF5A2 expression always had a better survival outcomes. G IHC analysis suggesting that eIF5A2 is highly expressed in NSCLC and is located in the cytoplasm. **P < 0.01.
